Funding search · EIN 841558631 · Chicago, IL

Pulmonary Fibrosis Foundation

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

22
grants reported
$2.1M
total given
2021–2024
filing years
$100,000
median grant

Based on grants this organization reported to the IRS for tax years 20212024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Funder website ↗Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

Grant history

All 22 reported grants, largest first.

  • $125,000

    Trustees of Columbia University in the City of New York · New York, NY · 2023

    Investigation of kif15 as a novel familial pulmonary fibrosis gene

  • $125,000

    Trustees of the University of Pennsylvania · Philadelphia, PA · 2023

    Nanotechnology targeting of alveolar epithelial proteostasis in pulmonary fibrosis

  • $122,500

    The Trustees of the University of Pennsylvania · Philadelphia, PA · 2022

    Nanotechnology targeting of alveolar epithelial proteostasis in pulmonary fibrosis

  • $122,500

    Trustees of Columbia University in the City of New York · New York, NY · 2022

    Investigation of kif15 as a novel familial pulmonary fibrosis gene

  • $100,000

    Cedars-Sinai Medical Center · Los Angeles, CA · 2024

    Regulation of her2 activation in fibroblast invasion and pulmonary fibrosis.

  • $100,000

    Johns Hopkins University School of Medicine · Baltimore, MD · 2024

    Pulmonary hypertension prediction in patients with interstitial lung disease

  • $100,000

    The Rector & Visitors of the University of Virginia · Charlottesville, VA · 2024

    The role of b-1 cells and igm in pulmonary fibrosis pathogensis

  • $100,000

    University of Kansas Medical Center Research Institute · Kansas City, KS · 2024

    Metabolomics of preclinical pulmonary fibrosis

  • $100,000

    Vanderbilt University Medical Center · Nashville, TN · 2024

    Hif2 modulation of alveolar repair in pulmonary fibrosis

  • $100,000

    Weill Medical College of Cornell University · New York, NY · 2024

    Associations of ct-assessed airway diameter and clinical outcomes in pulmonary fibrosis

  • $100,000

    Johns Hopkins University School of Medicine · Baltimore, MD · 2023

    Understanding current attitudes toward advance care planning and evaluation of the impact of an educational tool in patients with pulmonary fibrosis

  • $100,000

    The Board of Trustees of the Leland Stanford Junior University · Redwood, CA · 2023

    Tert expressing alveolar type ii cells as unipotent progenitors with expanded proliferative capacities

  • $100,000

    The Regents of the University of California San Diego · La Jolla, CA · 2023

    Characterization of phenotypic plasticity of ipf alveolar epithelial type ii cells

  • $100,000

    The Regents of the University of Michigan · Ann Arbor, MI · 2023

    Role of non-canonical ahr signaling in coronavirus exacerbations of pulmonary fibrosis

  • $100,000

    University of Wisconsin-Madison · Madison, WI · 2023

    Fibronectin-targeting peptide as a pet-based probe for active pulmonary fibrosis

  • $75,000

    The Regents of the University of California San Francisco · San Francisco, CA · 2022

    Development of a telehealth intervention targeting barriers to early guideline-concordant idiopathic pulmonary fibrosis care for rural populations

  • $75,000

    The Trustees of the University of Pennsylvania · Philadelphia, PA · 2022

    Metabolic dysfunction and epigenetic reprogramming in distal alveolar epithelial progenitor cell function and ipf

  • $75,000

    University of Chicago · Chicago, IL · 2022

    Identifying the impact of workplace exposures on quality of life, lung function, and survival across interstitial lung disease

  • $75,000

    Yale University · New Haven, CT · 2022

    Neuro-innate interactions in pulmonary fibrosis

  • $75,000

    National Jewish Health · Denver, CO · 2021

    See Part IV

  • $75,000

    University of California San Francisco · San Francisco, CA · 2021

    See Part IV

  • $75,000

    Virginia Commonwealth University · Richmond, VA · 2021

    See Part IV

Who else funds this kind of work

Same state

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.